Antibacterial effect of Jordanian propolis and isolated flavonoids against human pathogenic bacteria

African Journal of Biotechnology

Volumn 9, Issue 36, 2010, Pages 5966-5974

  Darwish, Rula M ^a   Fares, Ra'ed J Abu ^a   Zarga, Musa H Abu ^a   Nazer, Ibrahim K ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Antibacterial activity; Escherichia coli; Flavonoids; Human pathogens; Methicillin resistant Staphylococcus aureus; Propolis

Indexed keywords

CEFALEXIN; CHRYSIN; CLINDAMYCIN; FLAVONOID; METHANOL; NALIDIXIC ACID; PENICILLIN G; PINOBANKSIN 3 O ACETATE; PINOCEMBERIN; PROPOLIS; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; ESCHERICHIA COLI; IN VITRO STUDY; JORDAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; OAK; PINE;

ESCHERICHIA COLI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 77957586844     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Abd El Hady FK, Hegazi AG (2002). Egyptian Propolis: Chemical composition, antiviral and antimicrobial activities of East Nile Delta propolis. Z Naturforsch. 57: 386-394.
2. Bankova VS, Castro DSL, Marcucci MC (2000). Propolis: recent advances in chemistry and plant origin. Apidologie, 31: 3-15.
3. Burdoc GA (1998). Review of the biological properties and toxicity of bee propolis. Food Chem Toxicol. 36: 347-363.
4. Chen LJ, Games DE, Jones J (2003). Isolation and identification of four flavonoid constituents from the seeds of oroxylum indicum by highspeed conter-current chromatography. J. Chromatogr. 988: 95-105.
5. Darwish RM, Abu Fares R, Abu Zarga M, Nazer I (2009). Antifungal activity of Jordanian propolis on different resistant and standard species of Candida. Mellifera. 9-18: 23-32.
6. Fang JM, Su WC, Cheng YS (1988). Flavonoids and Stilbenes from Armand Pine. Phytochemisrty, 27: 1395-1397.
7. Fluit AC, Jones ME, Schmitz FJ, Acar JG, Verhoef J (2000). Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997-1998. Clin. Infect. Dis. 30: 454-60.
8. Gonzalez BG, Martinez-Aguilar G, Hulten KG (2005). Severe staphylococcal sepsis in adolescents in the era of communityacquired methicillin-resistant Staphylococcus aureus. Pediatrics, 115: 642-648.
9. Hegazi AG, Abd El Hady FK (2002). Egyptian propolis: 3. antioxidant, antimicrobial activities and chemical composition of propolis from reclaimed lands. Z Naturforsch. 57: 395-402.
10. Huang Y-C, Chou Y-H, Su L-H, Lien R-I, Lin T-Y (2006). Methicillin-Resistant Staphylococcus aureus colonization and Its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics, 118: 469-474.
11. Jung JH, Pummangura S, Chaichantipyuth C, Patarapanich C, Mclaughlin JL (1990). Bioactive constituents of melodorum fruticosum. Phytochemistry, 29: 1667-1670.
12. Karlowsky JA, Jones ME, Draghi DC, Thornsberry C, Sahm DF, Volturo GA (2004). Prevalence of antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann. Clin. Microbiol. Antimicrob. 3: p. 7. (Open Access article).
13. Kartal M, Yi{dotless}ldi{dotless}z S, Kaya S, Kurucu S, Topçu G (2003). Antimicrobial activity of propolis samples from two different regions of Anatolia. J. Ethnopharmacol. 86: 69-73.
14. Katircio H, Nazime M (2006). Antimicrobial activity and chemical compositions of Turkish propolis from different regions. Afr. J. Biotechnol. 5: 1151-1153.
15. Koo H, Rosalen PL, Cury JA, Park YK, Bowen WH (2002). Effects of compounds found in propolis on Streptococcus mutans growth and on glucosyltransferase activity. Antimicrob. Agents Chem. 46: 1302-1309.
16. Kosalec I, Bakmaz M, Pepeejnjak S, Knežević SV (2004). Quantitative analysis of the flavonoids in raw propolis from northern Croatia. Acta Pharmaceut. 54: 65-72.
17. Kujumgiev A, Tsvetkova I, Serkedjieva Y, Bankova V, Christov R, Popov S(1999). Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmacol. 64: 235-240.
18. Marcucci MC (1995). Propolis: chemical composition, biological properties and therapeutical activity. Apidologie, 26: 83-99.
19. Moreno MIN, Isla MI, Cudmani NG, Vattuone MA,Sampietro AR (1999). Screening of antibacterial activity of Amaicha del Valle (Tucumán, Argentina) propolis. J. Ethnopharmacol. 68: 97-102.
20. National Committee for Clinical Laboratory Standards (NCCLS) (2000a). Performance standards for antimicrobial susceptibility testing: eighth informational supplement. NCCLS document M100- S8. NCCLS, Villanova, PA.
21. National Committee for Clinical Laboratory Standards (NCCLS) (2000b). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard, 5th edn; M7-A5; Vol. 20, No. 2, replaces M7-A4, Vol. 17, No. 2.
22. Onlen Y, Duran N, Atik E, Savas L, Altug E, Yakan S, Aslantas O (2007). Antibacterial activity of propolis against MRSA and synergism with topical Mupirocin. J. Altern. Complement Med. 13: 713-718.
23. Park YK, Alencar SM, Aguiar CL (2005). Botanical Origin and Chemical Composition of Brazilian Propolis. J. Agric. Food Chem. 50: 2502-2506.
24. Prytzyk E, Dantas AP, Salomão K, Pereira AS, Bankova VS, De Castro SL, Neto FRA (2003). Flavonoids and trypanocidal activity of Bulgarian propolis. J. Ethnopharmacol. 88: 189-193.
25. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA (2001). Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States. Antimicrob. Agents Chem. 45: 1402-1406.
26. SAS/STAT User's Guide (1990). Version 6, 4th ed. SAS Institute Inc. Cary, NC, USA.
27. Schwaber MJ, Navon-Venezia S, Kaye KS, Ami RB, Schwartz D, Carmeli1 Y (2006). Clinical and economic impact of bacteremia with extended-spectrum-ß-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chem. 50: 1257-1262.
28. Sforcin JM, Fernandes JRA, Lopes, CAM, Bankova V, Funari SRC (2000). Seasonal effect on Brazilian propolis antibacterial activity. J. Ethnopharmacol. 73: 243-249.
29. Stepanović S, Antić N, Dakić I, Vlahović (2003). In vitro antimicrobial activity of propolis and synergism between propolis and antimicrobial drugs. Microbiol. Res. 158: 353-357.
30. Tegos G, Stermitz, FR, Lomovskaya O, Lewis K (2002). Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob Agents Chem. 46: 3133-3141.
31. Trusheva B, Popova M, Bankova V, Simova S, Marcucci MC, Miorin PL, Pasin FR, Tsvetkova I (2006). Bioactive constituents of Brazilian red propolis. Evid-Based Compl. Alt. 3: 294-254.
32. Yaghoubi SMJ, Ghorbani GR, Soleimanian Zad S, Satari R (2007). Antimicrobial activity of Iranian propolis and its chemical composition. DARU, 15: 45-48.